Cargando…

Epigenetic Reader Bromodomain Containing Protein 2 Facilitates Pathological Cardiac Hypertrophy via Regulating the Expression of Citrate Cycle Genes

The bromodomain and extra-terminal domain proteins (BETs) family serve as epigenetic “readers”, which recognize the acetylated histones and recruit transcriptional regulator complexes to chromatin, eventually regulating gene transcription. Accumulating evidences demonstrate that pan BET inhibitors (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhirong, Li, Zhenzhen, Guo, Zhen, Cao, Yanjun, Li, Jingyan, Liu, Peiqing, Li, Zhuoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174549/ https://www.ncbi.nlm.nih.gov/pubmed/35694272 http://dx.doi.org/10.3389/fphar.2022.887991

Ejemplares similares

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2019)

PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
por: Cai, Sidong, et al.
Publicado: (2020)

The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2021)

Orchestrating epigenetic readers: Progress in understanding the functions of bromodomain-containing protein 4 complexes
por: Brasier, Allan R.
Publicado: (2023)

Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
por: Morgado-Pascual, Jose Luis, et al.
Publicado: (2019)

Epigenetic Reader Bromodomain-Containing Protein 4 in Aging-Related Vascular Pathologies and Diseases: Molecular Basis, Functional Relevance, and Clinical Potential
por: Zheng, Xiaoxu, et al.
Publicado: (2023)

A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
por: Zhou, Zijun, et al.
Publicado: (2020)

The BRPF1 bromodomain is a molecular reader of di-acetyllysine
por: Obi, Juliet O., et al.
Publicado: (2020)

The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy
por: Wang, Luping, et al.
Publicado: (2022)

Effect of Triptolide on Temporal Expression of Cell Cycle Regulators During Cardiac Hypertrophy
por: Li, Jing-Mei, et al.
Publicado: (2020)

Pharmacokinetics and absorption mechanism of tandospirone citrate
por: Li, Rong, et al.
Publicado: (2023)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
por: Zhu, Fuyu, et al.
Publicado: (2022)

Metformin With or Without Clomiphene Citrate Versus Laparoscopic Ovarian Drilling With or Without Clomiphene Citrate to Treat Patients With Clomiphene Citrate-Resistant Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Sun, Ming-Li, et al.
Publicado: (2022)

Shengui Sansheng San Ameliorates Cerebral Energy Deficiency via Citrate Cycle After Ischemic Stroke
por: Luo, Cheng, et al.
Publicado: (2019)

Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma
por: Vichaikul, Sirapa, et al.
Publicado: (2022)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

A chemical toolbox for the study of bromodomains and epigenetic signaling
por: Wu, Qin, et al.
Publicado: (2019)

Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials
por: Sun, Yanli, et al.
Publicado: (2021)

Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC
por: Lee, Jang Hyuck, et al.
Publicado: (2021)

SIRT3 improved peroxisomes-mitochondria interplay and prevented cardiac hypertrophy via preserving PEX5 expression
por: Wang, Minghui, et al.
Publicado: (2023)

Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis
por: Yang, Minghua, et al.
Publicado: (2022)

Functional networks of the human bromodomain-containing proteins
por: Gao, Cong, et al.
Publicado: (2022)

Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins
por: Chabert, Clovis, et al.
Publicado: (2017)

Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations
por: Shi, Mingsong, et al.
Publicado: (2023)

Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation
por: Martella, Noemi, et al.
Publicado: (2023)

Pharmacological suppression of Nedd4-2 rescues the reduction of Kv11.1 channels in pathological cardiac hypertrophy
por: Zhang, Hua, et al.
Publicado: (2022)

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022)

Drug Discovery Targeting Bromodomain-Containing Protein 4
por: Liu, Zhiqing, et al.
Publicado: (2017)

Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis
por: Wang, Ranran, et al.
Publicado: (2020)

Bromodomain-containing factor GTE4 regulates Arabidopsis immune response
por: Zhou, Qin, et al.
Publicado: (2022)

Identification of bromodomain-containing protein 4 (BRD4) as a novel marker and epigenetic target in mast cell leukemia
por: Wedeh, Ghaith, et al.
Publicado: (2015)

Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?
por: Yan, Qiqi, et al.
Publicado: (2021)

Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins
por: Li, Junlin, et al.
Publicado: (2013)

Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Yu, Jing, et al.
Publicado: (2021)

PBRM1 bromodomains associate with RNA to facilitate chromatin association
por: De Silva, Saumya M, et al.
Publicado: (2023)

Single Dose Study Assessing the Pharmacokinetic and Metabolic Profile of Alverine Citrate in Healthy Volunteers
por: Rizea-Savu, Simona, et al.
Publicado: (2021)

Network Pharmacology and In Vitro Experimental Verification Reveal the Mechanism of the Hirudin in Suppressing Myocardial Hypertrophy
por: Liu, Mengnan, et al.
Publicado: (2022)

Dangshen Erling Decoction Ameliorates Myocardial Hypertrophy via Inhibiting Myocardial Inflammation
por: Zhong, Yigang, et al.
Publicado: (2022)

Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure
por: Mayer, Sandra C., et al.
Publicado: (2015)

Chemical basis for the recognition of trimethyllysine by epigenetic reader proteins
por: Kamps, Jos J.A.G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_epf5aoaqu6vo0pc1d1qabuu3bg